Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

BACKGROUND: Obesity is an independent adverse prognostic factor in early breast cancer patients, but it is still controversial whether obesity may affect adjuvant endocrine therapy efficacy. The aim of our study (ancillary to the two clinical trials Gruppo Italiano Mammella (GIM)4 and GIM5) was to i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sini, V, Lunardi, G, Cirillo, M, Turazza, M, Bighin, C, Giraudi, S, Levaggi, A, Piccioli, P, Bisagni, G, Gnoni, R, Stridi, G, Porpiglia, M, Picardo, E, Ponzone, R, Marenco, D, Mansutti, M, Puglisi, F, Del Mastro, L
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2014
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950872/
https://ncbi.nlm.nih.gov/pubmed/24448359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares